Loading [Contrib]/a11y/accessibility-menu.js
Skip to main content
JHEOR
Menu
Articles
Author Correction
Autoimmune Diseases
Brief Report
Cardiovascular Conditions
Commentary
Correspondence
Dermatological Diseases
Endocrine Diseases
Gastrointestinal Conditions
General Indications
Genetic Disorders
Hematology
Infectious Diseases
Methodology and Healthcare Policy
Nephrologic/Hepatologic Conditions
Neurological Disorders
Oncology
Ophthalmology
Other Conditions
Perspective
Psychological Conditions
Respiratory Diseases
Trauma Induced Conditions
Urological/Gynecological Diseases
All
For Authors
Editorial Board
About
Issues
Blog
Journal Policies
For Reviewers
search
RSS Feed
Enter the URL below into your favorite RSS reader.
https://jheor.org/feed
×
Articles
⁄
Impact of a Novel Insulin...
⁄
Metrics
Metrics
Impact of a Novel Insulin Management Service on Non-insulin Pharmaceutical Expenses
John E. Schneider
,
Anjani Parikh
,
Ivana Stojanovic
,
insulin management device
diabetes
economic evaluation
• https://doi.org/10.36469/9783
Pageviews and PDF downloads
Pageviews
Downloads
4
past 30 days
Last 7 days
Last 30 days
Last 90 days
All time
Top Countries
US
4